Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit? (original) (raw)

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Bonnenkamp JJ, Hermans J, Sasako M, van de Velde CJH, et al. Extended lymph node dissection for gastric cancer. N Engl J Med 1999;340:908–14.
    Article CAS PubMed Google Scholar
  2. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical co-operation group. Br J Cancer 1999;79:1522–30.
    Article CAS PubMed Google Scholar
  3. Brennan MF. Lymph node dissection for gastric cancer (editorial). N Engl J Med 1999;340:956–8.
    Google Scholar
  4. Degiuli M, Sasako M, Soldati T, et al. Results of the Italian Gastric Cancer Study Group prospective multi-center surgical trial on D2-gastrectomy for gastric cancer. In: Kim JP, Min JS, Mok YJ eds. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. Monduzzi Editore, Bologna (Italy), 1999, pp155–161.
  5. Nishi M, Omori Y, Miwa K, eds. Japanese Classification of Gastric Carcinoma. Japanese Research Society for Gastric Cancer (JRSGC). 1st English edition. Tokyo: Kanehara & Co., 1995.
  6. Marujama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418–25.
    Google Scholar
  7. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-.
    Google Scholar
  8. Black N. Evidence-based surgery: A passing fad? World J Surg 1999;23:789–93.
    Article CAS PubMed Google Scholar
  9. Siewert JR, Boettcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–61.
    Google Scholar
  10. Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended lymphadenectomy in Western gastric cancer patients based on a new concept. A prospective long-term follow-up study. Surgery 1998;123:573–8.
    Google Scholar
  11. Bunt AMG Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparison of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19–25.
    CAS PubMed Google Scholar
  12. Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer (review). Ann Surg Oncol 1999;6:46–56.
    Google Scholar
  13. Roukos DH. Therapeutic value of D2-resection in gastric cancer evaluated with a new concept. UICC Concensus Conference. In: Kim JP, Min JS, Mok YJ eds. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. Monduzzi Editore, Bologna (Italy), 1999, pp. 29–33.
  14. Katai H, Marujam K, Sasako M, Sano T. Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodes. Gastric Cancer 1998;1:115–7.
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Medical School, University of Ioannina, Greece
    Dimitrios H. Roukos MD
  2. University Hospital of Frankfurt, Frankfurt, Germany
    Dimitrios H. Roukos MD
  3. Roma 19, GR-452 21, Ioannina, Greece
    Dimitrios H. Roukos MD

Authors

  1. Dimitrios H. Roukos MD
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toDimitrios H. Roukos MD.

Rights and permissions

About this article

Cite this article

Roukos, D.H. Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit?.Ann Surg Oncol 7, 253–255 (2000). https://doi.org/10.1007/s10434-000-0253-0

Download citation